Atopic Dermatitis (ROCKET-SHUTTLE Study)
A study to evaluate the efficacy of rocatinlimab in combination with topical corticosteroid compared with a placebo for Atopic Dermatitis.
Texas,
A study to evaluate the efficacy of rocatinlimab in combination with topical corticosteroid compared with a placebo for Atopic Dermatitis.
This study evaluates the efficacy of rocatinlimab compared with a placebo assessed using Validated Investigator’s Global Assessment for patients with Atopic Dermatitis.
The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subjects with Atopic Dermatitis.
The study is focused on skin of color participants who have moderate-to-severe atopic dermatitis with the aim to test the safety and effectiveness of the study drug.
A study to quantify deficits in cognitive functioning in adolescents with moderate-to-severe Atopic Dermatitis, using the Conners’ Continuous Performance Test 3rd Edition.
A study to evaluate the long-term safety of difamilast ointment 1% in subjects ≥2 years of age with mild to moderate Atopic Dermatitis.
The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) previously treated with Dupilumab.
A randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
A study on comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis.
A clinical trial to evaluate lebrikizumab in adult participants with moderate-to-severe Atopic Dermatitis previously treated with Dupilumab.
A clinical trial to evaluate rocatinlimab in monotherapy treatment with moderate-to-severe Atopic Dermatitis in adults.
A clinical trial to study the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe Atopic Dermatitis
A clinical trial to evaluate oral upadacitinib to subcutaneous dupilumab with moderate-to-severe Atopic Dermatitis in adults & adolescents.
A clinical trial to assess the long-term safety of Dupilumab administered in Participants ≥6 Months to 18 years of age with Atopic Dermatitis.
A clinical trial of a longitudinal observational study of patients undergoing therapy for IMISC (TARGET-DERM).
A prospective sample collection study using non-invasive methods to investigate biomarkers in Atopic Dermatitis patients
A clinical trial of PDE4 inhibition with roflumilast for the management of Seborrheic Dermatitis (STRATUM Study).
Corrona Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness
Input your search keywords and press Enter.